PURE Bioscience, Inc. (PURE) Operating income 2016–2025
PURE Bioscience, Inc. (PURE) annual operating income history from SEC filings — each fiscal year as reported.
-$2.3MFY2025 · since FY2016: -$7.1M → -$2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.3M | +28.8% |
| FY2024 | -$3.2M | +19.1% |
| FY2023 | -$3.9M | -5.9% |
| FY2022 | -$3.7M | -61.1% |
| FY2021 | -$2.3M | -57875.0% |
| FY2020 | $4,000 | +100.1% |
| FY2019 | -$5.6M | +20.6% |
| FY2018 | -$7.0M | -17.2% |
| FY2017 | -$6.0M | +14.9% |
| FY2016 | -$7.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice